Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Esophageal Disorders
How would you approach endoscopic diagnosis and treatment of an area of visible nodularity concerning for cancer within long segment Barrett’s esophagus?
Related Questions
What prompts you to seek an alternative PPI versus escalating to PCAB therapy in patients with symptoms and sequelae of GERD who have clinically failed one PPI trial despite appropriate pre-prandial use?
How would you manage an elderly patient with type 3 achalasia who previously underwent POEM and has recurrent dysphagia, high Eckardt score, and dilated esophagus concerning for blown-out myotomy on esophagram?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
What therapies would be considered safe and effective in pregnant patients with EoE?
How will the findings from the recent BOSS study affect your management of Barrett's esophagus without dysplasia?
How would you manage long-segment Barrett's esophagus with both LGD and HGD that has failed to respond to RFA, cryoablation, or even Nissen fundoplication for large hiatal hernia?
How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?
What Barrett's Esophagus screening protocol do you follow for patients with scleroderma given the increased risk of reflux and esophageal stasis?
In patients with EGJOO on esophageal manometry, how do you approach subsequent testing for further evaluation?
How do you approach a referral for findings of intestinal metaplasia on a biopsy of an irregular z-line?
